CELL, MOLECULAR AND ANIMAL CORE
细胞、分子和动物核心
基本信息
- 批准号:7192128
- 负责人:
- 金额:$ 30.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAlzheimer&aposs DiseaseAnimal ModelAnimalsBudgetsCell modelCellsChronicConsultationsDisease ProgressionDoctor of PhilosophyEducational ActivitiesEmergency SituationEquipmentFosteringFundingGoalsGrantHuman ResourcesInflammationInternationalLipidsMissouriMolecularNeuronal DysfunctionOxidative StressPathogenesisPhenotypePrevention strategyProgram Research Project GrantsResearchResearch PersonnelResearch Project GrantsResearch TrainingResourcesSeriesSignal PathwayTraining ProgramsUniversitiesVisitcostdesigninnovationprogramsrepairedsuccesssymposium
项目摘要
The University of Missouri-Columbia (MU) Program Project Grant (PPG), Cell Models for AD: Lipids and
Related Signaling Pathways, is a comprehensive research and training program that investigates the impact
of oxidative stress and oligomeric Ap on neuronal dysfunction and chronic inflammation using appropriate
cell and animal models that express different phenotypes of AD. The Administrative Core is a key
component for the success of the PPG. The overall goal of the Administrative Core, led by Grace Y. Sun,
PhD, is to provide cohesiveness to the PPG by overseeing and supervising Research Projects and Cores.
This effort includes, but is not limited to, the administration of the budget and high cost resources, the
coordination of visits by invited speakers, the organization of meetings for the internal and external advisory
boards, and interactions with other NIA- funded investigators conducting research on Alzheimer's disease
and NIA Program Officers. The PPG is comprised of three highly integrated projects and two cores. Specific
aims for Core A are: 1) Coordinate and oversee the PPG administrative activities; 2) Foster interactions
among PPG researchers; 3) Organize a seminar series to focus on AD and related subjects; 4) Provide
statistical consultations; 5) Provide emergency funds for equipment repair or replacement of small
equipment; 6) Design a website for the PPG; 7) Establish the Advisory Committee; and 8) Organize national
and international symposia and meetings of the PPG Executive Committee. With the exception of partial
support for personnel, major support for Administrative Core A is through a grant from the University of
Missouri-Columbia PRIME Fund. MU will provide funds to establish new educational activities by supporting
visits of seminar speakers to the MU campus, by organizing local, national and international symposia that
will enhance research on the pathogenesis of AD, and by promoting innovative strategies for the prevention
and retardation of disease progression.
密苏里大学哥伦比亚分校 (MU) 计划项目拨款 (PPG),AD 细胞模型:脂质和
相关信号通路是一项综合研究和培训计划,旨在调查其影响
氧化应激和寡聚Ap对神经元功能障碍和慢性炎症的影响
表达不同 AD 表型的细胞和动物模型。行政核心是关键
PPG 成功的重要组成部分。由 Grace Y. Sun 领导的行政核心的总体目标,
博士的职责是通过监督和监督研究项目和核心来为 PPG 提供凝聚力。
这项工作包括但不限于预算和高成本资源的管理、
协调受邀演讲者的访问,组织内部和外部咨询会议
董事会以及与其他 NIA 资助的研究人员进行阿尔茨海默病研究的互动
和 NIA 项目官员。 PPG由三个高度集成的项目和两个核心组成。具体的
核心 A 的目标是: 1) 协调和监督 PPG 行政活动; 2)促进互动
PPG 研究人员; 3)组织一系列研讨会,重点关注AD及相关主题; 4)提供
统计咨询; 5)为设备维修或更换小型设备提供应急资金
设备; 6)为PPG设计一个网站; 7)设立咨询委员会; 8) 组织全国
以及 PPG 执行委员会的国际研讨会和会议。除部分情况外
人员支持,行政核心 A 的主要支持是通过大学的拨款
密苏里-哥伦比亚 PRIME 基金。密苏里大学将提供资金支持开展新的教育活动
通过组织地方、国家和国际研讨会,研讨会演讲者访问密苏里大学校园
将加强对AD发病机制的研究,并通过促进预防创新策略
和延缓疾病进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY Andrew WEISMAN其他文献
GARY Andrew WEISMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY Andrew WEISMAN', 18)}}的其他基金
The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
ATP 的 P2X7 受体作为预防辐射引起的唾液腺功能障碍的治疗靶点
- 批准号:
10659723 - 财政年份:2023
- 资助金额:
$ 30.8万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10685136 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10554383 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10360664 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10788973 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
- 批准号:
10219752 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
2017 Salivary Glands and Exocrine Biology Gordon Research Conference & Gordon Research Seminar
2017年唾液腺与外分泌生物学戈登研究会议
- 批准号:
9248729 - 财政年份:2016
- 资助金额:
$ 30.8万 - 项目类别:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
- 批准号:
8630757 - 财政年份:2013
- 资助金额:
$ 30.8万 - 项目类别:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
通过减少核苷酸诱导的炎症来恢复唾液腺功能
- 批准号:
9185314 - 财政年份:2013
- 资助金额:
$ 30.8万 - 项目类别:
The Regulation of Salivary Gland Regeneration by P2Y2 Nucleotide Receptors
P2Y2核苷酸受体对唾液腺再生的调控
- 批准号:
7932509 - 财政年份:2009
- 资助金额:
$ 30.8万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:
10753675 - 财政年份:2023
- 资助金额:
$ 30.8万 - 项目类别:
Racial/Ethnic Disparities in Health Care and Challenges in Insurance Plan Choices among Older People with Alzheimer’s Disease and Related Dementia: A Mixed Methods Study of Medicare Options
患有阿尔茨海默病和相关痴呆症的老年人在医疗保健方面的种族/民族差异以及保险计划选择的挑战:医疗保险选项的混合方法研究
- 批准号:
10723148 - 财政年份:2023
- 资助金额:
$ 30.8万 - 项目类别: